Nuclear Medicine Market Size 2025-2029
The nuclear medicine market size is forecast to increase by USD 13.01 billion at a CAGR of 19.2% between 2024 and 2029.
- The market is experiencing significant growth, driven by the increasing adoption of advanced imaging technologies such as single-photon emission computed tomography (SPECT) and SPECT/CT hybrid systems. These innovative imaging solutions offer enhanced diagnostic capabilities, improving medical diagnostics and enabling early detection of various diseases. Additionally, the minimal side effects of radiopharmaceuticals, compared to their potential benefits, are fueling market growth. However, regulatory hurdles related to the preparation and distribution of radiopharmaceuticals pose challenges to market expansion. In the field of cancer treatment, the integration of nuclear medicine with chemotherapy methods is gaining traction, further expanding the market's scope. Technological advancements in medical diagnostics, including the development of MRI systems and X-ray crystallography, are also contributing to the market's growth trajectory.
What will be the Size of the Nuclear Medicine Market During the Forecast Period?

Request Free Sample
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Nuclear Medicine Market 2019 - 2023
- Historic Market Size - Data Table on Global Nuclear Medicine Market 2019 - 2023 ($ million)
- 5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
- 5.3 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
- 5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on the Global Nuclear Medicine Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
- 8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
- 8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 8.3 Radiotherapeutics - Market size and forecast 2024-2029
- Chart on Radiotherapeutics - Market size and forecast 2024-2029 ($ million)
- Data Table on Radiotherapeutics - Market size and forecast 2024-2029 ($ million)
- Chart on Radiotherapeutics - Year-over-year growth 2024-2029 (%)
- Data Table on Radiotherapeutics - Year-over-year growth 2024-2029 (%)
- 8.4 Equipment (SPECT and PET) - Market size and forecast 2024-2029
- Chart on Equipment (SPECT and PET) - Market size and forecast 2024-2029 ($ million)
- Data Table on Equipment (SPECT and PET) - Market size and forecast 2024-2029 ($ million)
- Chart on Equipment (SPECT and PET) - Year-over-year growth 2024-2029 (%)
- Data Table on Equipment (SPECT and PET) - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Application
- 9.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
- 9.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 9.3 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ million)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)
- 9.4 Cardiology - Market size and forecast 2024-2029
- Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
- Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
- Chart on Cardiology - Year-over-year growth 2024-2029 (%)
- Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
- 9.5 Neurology - Market size and forecast 2024-2029
- Chart on Neurology - Market size and forecast 2024-2029 ($ million)
- Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
- Chart on Neurology - Year-over-year growth 2024-2029 (%)
- Data Table on Neurology - Year-over-year growth 2024-2029 (%)
- 9.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 9.7 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 11.4 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 11.5 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 11.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 11.8 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 11.9 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 11.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 11.11 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 11.12 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 11.13 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 11.14 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 11.15 Australia - Market size and forecast 2024-2029
- Chart on Australia - Market size and forecast 2024-2029 ($ million)
- Data Table on Australia - Market size and forecast 2024-2029 ($ million)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- 11.16 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 11.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
12 Drivers, Challenges, and Opportunity/Restraints
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 12.4 Market opportunities/restraints
13 Competitive Landscape
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14.2 Company ranking index
- 14.3 Market positioning of companies
- Matrix on companies position and classification
- 14.4 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- 14.5 Bracco Spa
- Bracco Spa - Overview
- Bracco Spa - Product / Service
- Bracco Spa - Key offerings
- SWOT
- 14.6 Cardinal Health Inc.
- Cardinal Health Inc. - Overview
- Cardinal Health Inc. - Business segments
- Cardinal Health Inc. - Key news
- Cardinal Health Inc. - Key offerings
- Cardinal Health Inc. - Segment focus
- SWOT
- 14.7 Eckert and Ziegler AG
- Eckert and Ziegler AG - Overview
- Eckert and Ziegler AG - Business segments
- Eckert and Ziegler AG - Key news
- Eckert and Ziegler AG - Key offerings
- Eckert and Ziegler AG - Segment focus
- SWOT
- 14.8 ECZACIBASI MONROL NUCLEAR PRODUCTS CO.
- ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Overview
- ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Product / Service
- ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Key offerings
- SWOT
- 14.9 GE Healthcare Technologies Inc.
- GE Healthcare Technologies Inc. - Overview
- GE Healthcare Technologies Inc. - Business segments
- GE Healthcare Technologies Inc. - Key news
- GE Healthcare Technologies Inc. - Key offerings
- GE Healthcare Technologies Inc. - Segment focus
- SWOT
- 14.10 IBA Radiopharma Solutions
- IBA Radiopharma Solutions - Overview
- IBA Radiopharma Solutions - Business segments
- IBA Radiopharma Solutions - Key news
- IBA Radiopharma Solutions - Key offerings
- IBA Radiopharma Solutions - Segment focus
- SWOT
- 14.11 Jubilant Pharmova Ltd.
- Jubilant Pharmova Ltd. - Overview
- Jubilant Pharmova Ltd. - Business segments
- Jubilant Pharmova Ltd. - Key news
- Jubilant Pharmova Ltd. - Key offerings
- Jubilant Pharmova Ltd. - Segment focus
- SWOT
- 14.12 Koninklijke Philips NV
- Koninklijke Philips NV - Overview
- Koninklijke Philips NV - Business segments
- Koninklijke Philips NV - Key news
- Koninklijke Philips NV - Key offerings
- Koninklijke Philips NV - Segment focus
- SWOT
- 14.13 Mallinckrodt Plc
- Mallinckrodt Plc - Overview
- Mallinckrodt Plc - Business segments
- Mallinckrodt Plc - Key news
- Mallinckrodt Plc - Key offerings
- Mallinckrodt Plc - Segment focus
- SWOT
- 14.14 Medi-Radiopharma
- Medi-Radiopharma - Overview
- Medi-Radiopharma - Product / Service
- Medi-Radiopharma - Key offerings
- SWOT
- 14.15 Necsa
- Necsa - Overview
- Necsa - Product / Service
- Necsa - Key offerings
- SWOT
- 14.16 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 14.17 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key news
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- 14.18 Sirtex Medical Pty Ltd.
- Sirtex Medical Pty Ltd. - Overview
- Sirtex Medical Pty Ltd. - Product / Service
- Sirtex Medical Pty Ltd. - Key offerings
- SWOT
15 Appendix
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations